Nivagen Pharmaceuticals Inc 2024-10-09 Health serious FDA
Health · FDA · Recall #FDA-D-0001-2025
Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured… Recall
Issued October 9, 2024 · Nivagen Pharmaceuticals Inc
In October 2024, Nivagen Pharmaceuticals Inc recalled the Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.
What you should do
- 1 Stop using Atorvastatin Calcium Tablets, USP, 40mg, Rx only, 1000 Tablets per bottle, Manufactured… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Nivagen Pharmaceuticals Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Nivagen Pharmaceuticals Inc
- Category
- Health
- Recall date
- October 9, 2024
- Units affected
- Not reported
- Sold at
- Nationwide within the U.S
- Recall number
- FDA-D-0001-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Nivagen Pharmaceuticals Inc has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.